Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON (JNJ)
Mes dernières consult.
Most popular
Rapport
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about JOHNSON & JOHNSON
08:33p JOHNSON & JOHNSON : The Fastest Growing Regions for Dermatological Drug Sales Ar..
08:29p JOHNSON & JOHNSON : Missouri court throws out $72M million verdict in Johnson & ..
05:21p JOHNSON & JOHNSON : Looking back on Black Monday, the stock market crash of 1987
04:30p Genmab Announces Net Sales of DARZALEX for Third Quarter of 2017
04:29p JOHNSON & JOHNSON : and Reports 2017 Third Quarter Results
02:29p ENDOLOGIX, INC. (NASDAQ : ELGX) Files An 8-K Departure of Directors or Certain O..
12:51p JOHNSON & JOHNSON : Announces Quarterly Dividend for Fourth Quarter 2017
12:11p JOHNSON & JOHNSON : Medical GmbH to Acquire Surgical Process Institute
10/18 JOHNSON & JOHNSON : Fades With Profit, Forecast
10/18 JOHNSON & JOHNSON : Missouri appeals court throws out $72 million award in Johns..
10/18 UNITEDHEALTH : Agloan-Dow, S&P Reach New Highs
10/18 JOHNSON & JOHNSON : Briefly Briefly
10/18DJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
10/18 JOHNSON & JOHNSON : Dow touches another record high point
10/18 JOHNSON & JOHNSON : Wins Reversal Of First St. Louis Talc-Cancer Verdict
More most relevant news
All news about JOHNSON & JOHNSON
08:33p JOHNSON & JOHNSON : The Fastest Growing Regions for Dermatological Drug Sales Ar..
08:29p JOHNSON & JOHNSON : Missouri court throws out $72M million verdict in Johnson & ..
05:21p JOHNSON & JOHNSON : Looking back on Black Monday, the stock market crash of 1987
04:30p Genmab Announces Net Sales of DARZALEX for Third Quarter of 2017
04:29p JOHNSON & JOHNSON : and Reports 2017 Third Quarter Results
02:29p ENDOLOGIX, INC. (NASDAQ : ELGX) Files An 8-K Departure of Directors or Certain O..
01:52p JOHNSON & JOHNSON : Earnings Review and Free Research Report: Johnson & Johnson ..
12:51p JOHNSON & JOHNSON : Announces Quarterly Dividend for Fourth Quarter 2017
12:11p JOHNSON & JOHNSON : Medical GmbH to Acquire Surgical Process Institute
10:38a UNITEDHEALTH : Markets summary with a ‘win-win’ deal
More news
Sector news : Pharmaceuticals - NEC
02:19pDJEuropean Corporate Roundup for Thursday
11:31aDJEuropean Corporate Roundup for Thursday
08:48aDJMERCK AND : Chenault Among Few Black CEOs -- WSJ
07:53aDJROCHE : 3Q Sales Increase on Strong Performance of Recently Launched Drugs
10/18DJMERCK AND : Amex Retirement Shines Light on Lack of Diversity in CEO Ranks
10/18 FTSE rises to record close, blue-chips shrug off Reckitt blip
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
09:25a Alcobra up 46% premarket on Arcturus/Janssen deal in HBV
07:40a Market Is Not Waiting For Tax Reform - Cramer's Mad Money (10/18/17)
07:31a Johnson & Johnson to acquire Surgical Process Institute
06:56a Johnson & Johnson declares $0.84 dividend
12:18a J&J : Unattractive
10/18 JOHNSON & JOHNSON : Fully Priced As Operating Momentum Accelerates
Qtime:0
Financials ($)
Sales 2017 76 224 M
EBIT 2017 23 484 M
Net income 2017 15 953 M
Debt 2017 16 378 M
Yield 2017 2,38%
P/E ratio 2017 24,13
P/E ratio 2018 19,71
EV / Sales 2017 5,17x
EV / Sales 2018 4,79x
Capitalization 378 B
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 144 $
Spread / Average Target 2,3%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Dominic J. Caruso Chief Financial Officer & Vice President
Paulus Stoffels Chief Scientific Officer & Executive VP
Charles O. Prince Independent Director
William David Perez Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON22.11%377 585
NOVARTIS13.50%226 453
ROCHE HOLDING LTD.5.55%215 760
PFIZER10.31%213 372
MERCK AND COMPANY7.88%173 214
AMGEN27.41%135 924